An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat

Experimental Neurology

Volumn 201, Issue 2, 2006, Pages 324-334

  Windle, Victoria ^a   Szymanska, Aleksandra ^a   Granter Button, Shirley ^a   White, Chistopher ^b   Buist, Richard ^b   Peeling, James ^b,c   Corbett, Dale ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

Animal; Behavior models; Endothelin 1; Imaging; Ischemia

Indexed keywords

ENDOTHELIN 1; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CONVALESCENCE; CORPUS STRIATUM; DIFFUSION COEFFICIENT; FORELIMB; HISTOLOGY; INTERMETHOD COMPARISON; MALE; MIDDLE CEREBRAL ARTERY; MOTOR CORTEX; MOTOR PERFORMANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SURVIVAL;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL CORTEX; CORPUS STRIATUM; DRUG ADMINISTRATION ROUTES; ENDOTHELIN-1; INJECTIONS; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MOTOR CORTEX; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS;

EID: 33748427771     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.04.012     Document Type: Article

References (42)

1. Adkins-Muir D.L., and Jones T.A. Cortical electrical stimulation combined with rehabilitative training: enhanced functional recovery and dendritic plasticity following focal cortical ischemia in rats. Neurol. Res. 25 (2003) 780-788
2. Back T., Hemmen T., and Schüler O. Lesion evolution in cerebral ischemia. J. Neurol. 251 (2004) 388-397
3. Bendel O., Alkass K., Bueters T., von Euler M., and von Euler G. Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Res. 1033 (2005) 135-142
4. Biernaskie J., and Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J. Neurosci. 21 (2001) 5272-5280
5. Biernaskie J., Corbett D., Peeling J., Wells J., and Lei H. A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn. Reson. Med. 46 (2001) 827-830
6. Biernaskie J., Chernenko G., and Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J. Neurosci. 24 (2004) 1245-1254
7. Buchan A.M., Xue D., and Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 23 (1992) 273-279
8. Callaway J.K., Lawrence A.J., and Jarrott B. AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion. Neuropharmacology 44 (2003) 787-800
9. Carmichael S.T. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2 (2005) 396-409
10. Cramer S.C. Clinical issues in animal models of stroke and rehabilitation. ILAR J. 44 (2003) 83-84
11. Detre J.A., Leigh J.S., Williams D.S., and Koretsky A.P. Perfusion imaging. Magn. Reson. Med. 23 (1992) 37-45
12. Dittmar M., Spruss T., Schuierer G., and Horn M. External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats. Stroke 34 (2003) 2252-2257
13. Dreier J.P., Kleeberg J., Petzold G., Priller J., Windmuller O., Orzechowski H.D., Lindauer U., Heinemann U., Einhaupl K.M., and Dirnagl U. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?. Brain 125 (2002) 102-112
14. Fuxe K., Bjelke B., Andbjer B., Grahn H., Rimondini R., and Agnati L.F. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. NeuroReport 8 (1997) 2623-2629
15. Gilmour G., Iversen S.D., O'Neill M.F., and Bannerman D.M. The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav. Brain Res. 150 (2004) 171-183
16. Ginsberg M.D., and Busto R. Rodent models of cerebral ischemia. Stroke 20 (1989) 1627-1642
17. Hama H., Kasuya Y., Sakurai T., Yamada G., Suzuki N., Masaki T., and Goto K. Role of endothelin-1 in astrocyte responses after acute brain damage. J. Neurosci. Res. 47 (1997) 590-602
18. Hossmann K. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36 (1994) 557-565
19. Kanemitsu H., Nakagomi T., Tamura A., Tsuchiya T., Kono G., and Sano K. Differences in the extent of primary ischemic damage between middle cerebral artery coagulation and intraluminal occlusion models. J. Cereb. Blood Flow Metab. 22 (2002) 1196-1204
20. Lei H., and Peeling J. A strategy to optimize signal-to-noise ratio in the one-coil arterial spin-tagging perfusion imaging. Magn. Reson. Med. 41 (1999) 563-568
21. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
22. Macrae I.M., Robinson M.J., Graham D.I., Reid J.L., and McCulloch J. Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J. Cereb. Blood Flow Metab. 13 (1993) 276-284
23. Marston H.M., Faber E.S., Crawford J.H., Butcher S.P., and Sharkey J. Behavioural assessment of endothelin-1 induced middle cerebral artery occlusion in the rat. NeuroReport 6 (1995) 1067-1071
24. McColl B.W., Carswell H.V., McCulloch J., and Horsburgh K. Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res. 997 (2004) 14-22
25. Modo M., Stroemer R.P., Tang E., Veizovic T., Sowniski P., and Hodges H. Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J. Neurosci. Methods 104 (2000) 99-109
26. Montoya C.P., Campbell-Hope L.J., Pemberton K.D., and Dunnett S.B. The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36 (1991) 219-228
27. Moyanova S., Kirov R., and Kortenska L. Multi-unit activity suppression and sensorimotor deficits after endothelin-1-induced middle cerebral artery occlusion in conscious rats. J. Neurol. Sci. 212 (2003) 59-67
28. Nakayama H., Jorgensen H.S., Raaschou H.O., and Olsen T.S. Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study. Arch. Phys. Med. Rehabil. 75 (1994) 394-398
29. Parker V.M., Wade D.T., and Langton Hewer R. Loss of arm function after stroke: measurement, frequency, and recovery. Int. Rehabil. Med. 8 (1986) 69-73
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press
31. Ploughman M., Granter-Button S., Chernenko G., Tucker B.A., Mearow K.M., and Corbett D. Endurance exercise regimens induce differential effects on brain-derived neurotrophic factor, synapsin-I and insulin-like growth factor I after focal ischemia. Neuroscience 136 (2005) 991-1001
32. Sanchez-Alvarez R., Tabernero A., and Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. J. Neurochem. 89 (2004) 703-714
33. Schallert T., Kozlowski D.A., Humm J.L., and Cocke R.R. Use-dependent structural events in recovery of function. Adv. Neurol. 73 (1997) 229-238
34. Sharkey J., and Butcher S.P. Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J. Neurosci. Methods 60 (1995) 125-131
35. Sharkey J., Ritchie I.M., and Kelly P.A. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 13 (1993) 865-871
36. Sharkey J., Butcher S.P., and Kelly J.S. Endothelin-1 induced middle cerebral artery occlusion: pathological consequences and neuroprotective effects of MK801. J. Auton. Nerv. Syst. 49 (1994) S177-S185 (Suppl)
37. Thomas D., Pell G., Lythgoe M., Gadian D., and Ordidge R. A quantitative method for fast diffusion imaging using magnetization-prepared TurboFLASH. Magn. Reson. Med. 39 (1998) 950-960
38. Tsuchidate R., He Q.P., Smith M.L., and Siesjo B.K. Regional cerebral blood flow during and after 2(hours of middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 17 (1997) 1066-1073
39. Ulug A., Beauchamp N.J., Bryan R., and van Zijl P. Absolute quantification of diffusion constants in human stroke. Stroke 28 (1997) 481-482
40. Windle V., and Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res. 1044 (2005) 25-32
41. Yanagisawa M., Kurihara H., Kimura S., Goto K., and Masaki T. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J. Hypertens., Suppl. 6 (1988) S188-S191
42. Zhu C.Z., and Auer R.N. Graded hypotension and MCA occlusion duration: effect in tansient focal ischemia. J. Cereb. Blood Flow Metab. 15 (1995) 980-988